<DOC>
	<DOCNO>NCT00148889</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety bilateral pallidal stimulation patient medically refractory primary cervical dystonia .</brief_summary>
	<brief_title>Double-Blind , Multicenter Study Assess Efficacy Bilateral Pallidal Stimulation Patients With Medically Refractory Primary Cervical Dystonia</brief_title>
	<detailed_description>Primary cervical dystonia ( CD ) affect 20-40/100.000 population . The disease chronic life-long . The therapy choice local intramuscular Botulinum Toxin injection give every three month . Oral medication anticholinergic dopamine deplete drug usually limit efficacy use limit intolerable side-effects . About 5-10 % CD patient develop neutralize antibody Botulinum Toxin . Two previous control multicenter trial show efficacy safety bilateral pallidal stimulation patient primary segmental generalize dystonia ( one study perform group ) . Following surgery , patient randomize 1:1 verum placebo stimulation period three month . Primary outcome measure TWSTRS ( Toronto Western Spasmodic Torticollis Rating Scale ) - validate widely accept physician-based outcome measure cervical dystonia . The independent TWSTRS raters movement disorder specialist unaware stimulation status ( verum/placebo ) compare TWSTRS-score baseline 3-months follow-up . Our hypothesis stimulate patient significantly well improvement dystonia compare without stimulation ( placebo group ) . After 3-months period , patient unblinded receive continuous effective stimulation implant system . Regular follow-up visit schedule every 12 month 5 year postoperatively ass long-term efficacy pallidal stimulation . Side-effects assess standardized way include assessment surgery-induced well stimulation-induced side-effects .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<criteria>Primary cervical dystonia Disease duration 3 year longer Adult patient ( 18 year old ) TWSTRS severity score 15 Nonresponse Botulinum Toxin Nonresponse oral antidystonic medication Informed consent Dementia ( Mattis Dementia Rating Scale 120 ) Severe depression ( Beck Depression Inventory &gt; 25 ) Previous functional stereotactic surgery Hemidystonia generalize dystonia Severe brain atrophy Contraindication surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>cervical dystonia</keyword>
	<keyword>torticollis</keyword>
	<keyword>deep brain stimulation</keyword>
	<keyword>pallidal stimulation</keyword>
	<keyword>globus pallidus internus</keyword>
</DOC>